The compounded semaglutide market has grown significantly, and whether compounded formulations carry the same allodynia risk as brand-name products is unknown
Matsuo, T., Suzuki, H., Hashiguchi, M
Ozempic, Wegovy, and Rybelsus are the only FDA-approved products containing semaglutide produced by Novo Nordisk, Inc., while Zepbound and Mounjaro are the only FDA-approved products containing tirzepatide produced by Lilly USA LLC.
Clinical trials consistently show weight loss of 1520% or more with GLP-1s, compared to 510% with medications like Contrave, orlistat, and phentermine
Root-Cause Treatment Lab work identifies insulin resistance, inflammation, thyroid issues, hormone imbalances and treats them alongside the medication
Metoprolol (Oral Route)